The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test

Anesthesia and Analgesia

Volumn 104, Issue 4, 2007, Pages 927-935

  Dogrul, Ahmet ^a   Gülmez, S Ezgi ^b   Deveci, M Salih ^a   Gul, Husamettin ^a   Ossipov, Michael H ^c   Porreca, Frank ^c   Tulunay, F Cankat ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; DIPYRONE; KETOROLAC TROMETAMOL; NALOXONE; SALICYLATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEAT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DICLOFENAC; DIPYRONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAPERITONEAL; KETOROLAC; LYSINE; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; REACTION TIME; SODIUM SALICYLATE; TAIL; TIME FACTORS;

EID: 34047261614     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000258773.46897.34     Document Type: Article

References (34)

1. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597-52.
2. Dogrul A, Yesilyurt O, Deniz G, Isimer A. Analgesic effects of amlodipine and its interaction with morphine and ketorolac-induced analgesia. Gen Pharmacol 1997;29:839-45.
3. Kolesnikov YA, Wilson RS, Pasternak GW. The synergistic analgesic interactions between hydrocodone and ibuprofen. Anesth Analg 2003;97:1721-3.
4. Miranda HF, Lopez J, Sierralta F, et al. NSAID antinociception measured in a chemical and a thermal assay in mice. Pain Res Manag 2001;6:190-6.
5. Miranda HF, Lemus I, Pinardi G. The effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Res Bull 2003;61:417-25.
6. Zelcer S, Kolesnikov Y, Kovalyshyn I, et al. Selective potentiation of opioid analgesia by nonsteroidal anti-inflammatory drugs. Brain Res 2005;1040:151-6.
7. Grossman ML, Basbaum AI, Fields HL. Afferent and efferent connections of the rat tail flick reflex (a model used to analyze pain control mechanisms). J Comp Neurol 1982;206:9-16.
8. Pinardi G, Sierralta F, Miranda HF. Adrenergic mechanisms in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice. Pharmacol Biochem Behav 2003;74:603-8.
9. Wong CS, Hsu MM, Chou R, et al. Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats. Br J Anaesth 2000;85:747-51.
10. Bareggi SR, Pirola R, De Benedittis G. Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherapeutic neuralgia. Eur J Clin Pharmacol 1998;54:231-5.
11. Pirola R, Bareggi SR, De Benedittis G. Determination of acetylsalicylic acid and salicylic acid in skin and plasma by high-performance liquid chromatography. J Chromatogr Biomed Sci Appl 1998;705:309-15.
12. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. New York: Springer-Verlag, 1987.
13. Lashbrook JM, Ossipov MH, Hunter JC, et al. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX-1-and COX-2 inhibitors in nerve-injured rats. Pain 1999;82:65-72.
14. Ulugol A, Ozyigit F, Yesilyurt O, Dogrul A. The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac. Anesth Analg 2006;102:443-7.
15. Suh H, Jun HW, Dzimianski MT, Lu GW. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats. Biopharm Drug Dispos 1997;18:623-33.
16. Hui X, Anigbogu A, Singh P, et al. Pharmacokinetic and local tissue disposition of [14C] sodium diclofenac following iontophoresis and systemic administration in rabbits. J Pharm Sci 2001;90:1269-76.
17. Nielsen LA, Chen ACN. Lasers and other thermal stimulators for activation of skin nociceptors. Clin Neurophysiol 2003;33:259-68.
18. Nolano M, Simone DA, Crabb GW, et al. Topical capsaicin in human; parallel loss of epidermal nerve fibers and pain sensation. Pain 1999;81:135-45.
19. Southall MD, Li T, Gharibova LS, et al. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003;304:217-22.
20. Stander S, Moormann C, Schumacher M, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004;13:129-39.
21. Southall MD ,Vasko MR. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 2001;276:16083-91.
22. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from clinic. FASEB 2004;18:790-804.
23. Scholz K, Furstenberger G, Muller-Decker K, Marks F. Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J 1995;309:263-9.
24. Dionne RA, Gordon SM, Rowan J, et al. Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation. J Oral Maxillofac Surg 2003;61:997-1003.
25. Khodorova A, Navarro B, Jouville LS, et al. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nature Med 2003;98:1055-61.
26. Ortiz MI, Soto VG, Hernandez GC. The NO-cGMP-K channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 2003;76:187-95.
27. Chen X, Gallar J, Belmonte C. Reduction by anti-inflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Ophthalmol Vis Sci 1997;38:1944-53.
28. Gold MS, Reichling DB, Hampl KF, et al. Lidocaine toxicity in primary afferent neurons from the rat. J Pharmacol Exp Ther 1998;285:413-21.
29. Szerenyi K, Sorken K, Garbus JJ, et al. Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 1994;118:312-15.
30. Stein R, Stein HA, Cheskes A, Symons S. Photorefractive keratectomy and postoperative pain. Am J Ophthalmol 1994;117:403-5.
31. Sher NA, Frantz JM, Talley A, et al. Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. Refract Corneal Surg 1993;9:425-36.
32. Eiferman RA, Hoffman RS, Sher NA. Topical diclofenac reduces pain following photorefractive keratectomy. Arch Ophthalmol 1993;1011:1022.
33. Aragona P, Tripodi G, Spinella R, et al. The effects of the topical administration of non-steroidal antiinflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye 2000;14:206-10.
34. Acosta MC, Berenguer-Ruiz L, Garcia-Galvez A, et al. Changes in mechanical, chemical, and thermal sensitivity of the cornea after topical application of nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 2005;46:282-6.